CMS Open Payments · Program Year 2024
Straumann USA LLC
Straumann USA LLC reported $7,575,646.79 across General Payments, Research, and Ownership to 35,784 physicians and teaching hospitals across 35,786 transactions.
- $7.6M
- All-tracks total
- 35,786
- Transactions
- 35,784
- Recipients
- +$438.5K
- General Payments vs PY2023
Straumann USA LLC reported $7,575,646.79 across all CMS Open Payments tracks (General + Research + Ownership) to 35,784 physicians and teaching hospitals in Program Year 2024 - ranking #216 of 1,925 reporting manufacturers (0.1% of the all-tracks industry total); General Payments alone were $7,566,212.86, averaging $211.70 per recipient.
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer straumann-usa-llc Straumann USA LLC
$7.6M · #216/1,925 · 0.1% industry · PY2024
- TOT $7.6M
- RANK #216
- SHARE 0.1%
- TXN 35,786
- RCP 35,784
- CAT 11
- GEN $7.6M
- ΔGEN +$438.5K
- TOP1 9.1%
- PY 2024
Volume peers
Nearest volume peer: DuraStat LLC ($7.6M)
Straumann USA LLC sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Straumann USA LLC's CMS-reported General Payments increased by $438.5K (+6.2%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: STRAUMANN USA LLCPY2023: STRAUMANN USA LLCPY2024: Straumann USA LLC. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $7,127,694.79
- PY2024
- $7,566,212.86
What the Data Shows for Straumann USA LLC
$7,575,646.79: that is what Straumann USA LLC reported in payments to 35,784 physicians and teaching hospitals during Program Year 2024, spread across 35,786 transactions ($211.69 per transaction, $211.70 per recipient). The company sits at rank #216 of 1,925, a comparatively small 0.1% slice of all industry payments reported nationwide for the year.
"Honoraria" leads the 11-category general-payment breakdown below at $1.9M (25.0% of General Payments, 419 transactions) - see our methodology for how research and ownership payments are reported separately.
General Payment Breakdown by Type
Across 11 types of general payments, Straumann USA LLC's largest category was "Honoraria" at $1.9M - 25.0% of General Payments.
Straumann USA LLC reports 11 general-payment categories - the top three are Honoraria (25.0%), Food and Beverage (16.7%), and Consulting Fee (15.3%). The remaining 8 categories make up 43.0% of this company's reported general-payment total. That multi-category mix is the kind of profile single-category reporters cannot show.
Category breadth matters here: Straumann USA LLC files across 11 named CMS general-payment types in Program Year 2024, versus manufacturers that report a single dominant category. The chart and table below enumerate every type with an amount above zero for this company.
How Straumann USA LLC divides its payments
Ranked by total dollars reported per category
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Honoraria | $1.9M | 419 | 25.0% |
| Food and Beverage | $1.3M | 25,997 | 16.7% |
| Consulting Fee | $1.2M | 104 | 15.3% |
| Compensation for Services Other Than Consulting | $1.1M | 1,846 | 14.3% |
| Education | $639.4K | 4,796 | 8.5% |
| Compensation for Faculty or Speaker (Medical Education) | $576.1K | 31 | 7.6% |
| Travel and Lodging | $368.8K | 397 | 4.9% |
| Debt Forgiveness | $348.0K | 78 | 4.6% |
| Grant | $111.0K | 2 | 1.5% |
| Gift | $78.6K | 1,418 | 1.0% |
| Entertainment | $50.1K | 696 | 0.7% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $1,984,084.46 (26.2%) of $7,566,212.86 in this company's General Payments records across 15,361 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Straumann USA LLC
The five named recipients with the highest reported General Payments from this company
- 1
Edmond Bedrossian
$689,395.38 across 87 reported transactions
- 2
Wael Att
$482,314.33 across 44 reported transactions
- 3
Todd Blair Engel
$441,071.78 across 30 reported transactions
- 4
Yan Kalika
$190,831.00 across 77 reported transactions
- 5
Aleksandar Jovanovic
$180,471.97 across 20 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Straumann USA LLC's, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Straumann USA LLC.
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Straumann USA LLC.
Showing 6 of 1,924 companies with CMS-reported payment data.
Asklepios Biopharmaceutical Inc.
Penumbra, Inc.
Exeltis, USA Inc.
Integrity Orthopaedics, Inc.
Skye Orthobiologics LLC
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.